Altria Research and Development Expenses 2012-2026 | MO
Altria annual/quarterly research and development expenses history and growth rate from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Altria research and development expenses for the quarter ending March 31, 2026 were $0M, a 0% increase year-over-year.
- Altria research and development expenses for the twelve months ending March 31, 2026 were $0M, a 0% increase year-over-year.
- Altria annual research and development expenses for 2025 were $0B, a 0% decline from 2024.
- Altria annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
- Altria annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
|
Altria Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
| 2013 | |
| 2012 | |
| 2011 | |
|
Altria Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | |
| 2025-12-31 | |
| 2025-09-30 | |
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $112.613B | $23.279B |
| Altria has a leading portfolio of tobacco products for U.S. tobacco consumers age 21 . Altria's wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, Altria owns Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Altria's smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, and Helix Innovations LLC (Helix), a rapidly growing manufacturer of oral nicotine pouches. Altria also owns equity investments in Anheuser-Busch InBev SA/NV (ABI), the world's largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $250.066B | 21.28 |
| British American Tobacco (BTI) | United Kingdom | $120.087B | 0.00 |
| JAPAN TOB (JAPAY) | Japan | $66.869B | 20.69 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $32.506B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.616B | 26.70 |
| Universal (UVV) | United States | $1.332B | 13.73 |
| Ispire Technology (ISPR) | United States | $0.100B | 0.00 |
| Charlie's Holdings (CHUC) | United States | $0.066B | 24.20 |
| 22nd Century (XXII) | United States | $0.001B | 0.00 |